Consun Pharmaceutical Group Ltd. (1681) Financial Statements

13 Followers

Consun Pharmaceutical Group Ltd. Financial Overview

Consun Pharmaceutical Group Ltd.'s market cap is currently HK$13.33B. The company's EPS TTM is HK$0.75; its P/E ratio is 11.34; and it has a dividend yield of 3.93%. Consun Pharmaceutical Group Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 3.33B	¥ 2.97B	¥ 2.59B	¥ 2.34B	¥ 2.04B
Gross Profit	¥ 2.60B	¥ 2.24B	¥ 1.92B	¥ 1.76B	¥ 1.53B
Operating Income	¥ 1.12B	¥ 1.05B	¥ 884.97M	¥ 757.33M	¥ 708.77M
EBITDA	¥ 1.18B	¥ 1.05B	¥ 963.06M	¥ 785.89M	¥ 728.71M
Net Income	¥ 1.05B	¥ 910.46M	¥ 784.53M	¥ 682.91M	¥ 590.17M
Balance Sheet
Cash & Short-Term Investments	¥ 3.95B	¥ 3.87B	¥ 3.58B	¥ 3.04B	¥ 2.43B
Total Assets	¥ 6.41B	¥ 5.85B	¥ 5.51B	¥ 4.89B	¥ 4.36B
Total Debt	¥ 213.01M	¥ 267.17M	¥ 511.53M	¥ 460.18M	¥ 610.97M
Net Debt	¥ -1.06B	¥ -2.64B	¥ -2.24B	¥ -1.99B	¥ -1.59B
Total Liabilities	¥ 1.56B	¥ 1.46B	¥ 1.59B	¥ 1.45B	¥ 1.45B
Stockholders' Equity	¥ 4.54B	¥ 4.10B	¥ 3.63B	¥ 3.15B	¥ 2.62B
Cash Flow
Free Cash Flow	¥ 1.14B	¥ 977.99M	¥ 766.41M	¥ 896.09M	¥ 627.29M
Operating Cash Flow	¥ 1.21B	¥ 1.09B	¥ 818.97M	¥ 947.68M	¥ 725.54M
Investing Cash Flow	¥ -2.15B	¥ -186.91M	¥ -231.77M	¥ -368.80M	¥ -298.31M
Financing Cash Flow	¥ -711.74M	¥ -729.26M	¥ -280.10M	¥ -342.20M	¥ -166.66M

Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History

Income Statement >

Consun Pharmaceutical Group Ltd. Debt to Assets

Balance Sheet >

Consun Pharmaceutical Group Ltd. Cash Flow

Cash Flow >

Consun Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

Earnings >